Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.

Liu G, Song L, Beasley DW, Putnak R, Parent J, Misczak J, Li H, Reiserova L, Liu X, Tian H, Liu W, Labonte D, Duan L, Kim Y, Travalent L, Wigington D, Weaver B, Tussey L.

Clin Vaccine Immunol. 2015 May;22(5):516-25. doi: 10.1128/CVI.00770-14. Epub 2015 Mar 11.


Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.

Wang YR, Wigington DP, Strugnell SA, Knutson JC.

Anticancer Res. 2005 Nov-Dec;25(6B):4333-9.


Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.

Wigington DP, Urben CM, Strugnell SA, Knutson JC.

Anticancer Res. 2004 Sep-Oct;24(5A):2905-12.


Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines.

Stampfer MR, Garbe J, Nijjar T, Wigington D, Swisshelm K, Yaswen P.

Oncogene. 2003 Aug 14;22(34):5238-51.


Production of knockout rats using ENU mutagenesis and a yeast-based screening assay.

Zan Y, Haag JD, Chen KS, Shepel LA, Wigington D, Wang YR, Hu R, Lopez-Guajardo CC, Brose HL, Porter KI, Leonard RA, Hitt AA, Schommer SL, Elegbede AF, Gould MN.

Nat Biotechnol. 2003 Jun;21(6):645-51. Epub 2003 May 18.


p57KIP2 expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells.

Nijjar T, Wigington D, Garbe JC, Waha A, Stampfer MR, Yaswen P.

Cancer Res. 1999 Oct 15;59(20):5112-8.


Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells.

Garbe J, Wong M, Wigington D, Yaswen P, Stampfer MR.

Oncogene. 1999 Apr 1;18(13):2169-80.

Supplemental Content

Loading ...
Support Center